0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eclampsia"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Pre-Eclampsia - Pipeline Insight, 2024 - Product Thumbnail Image

Pre-Eclampsia - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
From
EUR$4,200USDGBP
Pre-Eclampsia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pre-Eclampsia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$2,000USDGBP
Immunology of Pregnancy 2013 - Product Thumbnail Image

Immunology of Pregnancy 2013

  • Book
  • November 2013
  • 982 Pages
EUR$149USDGBP
EUR$98USDGBP
EUR$97USDGBP
EUR$202USDGBP
Critical Care Obstetrics. 5th Edition - Product Thumbnail Image

Critical Care Obstetrics. 5th Edition

  • Book
  • October 2010
  • 760 Pages
EUR$200USDGBP
EUR$192USDGBP
EUR$222USDGBP
EUR$98USDGBP
Obesity and Obstetrics. Edition No. 2 - Product Thumbnail Image

Obesity and Obstetrics. Edition No. 2

  • Book
  • June 2020
  • 372 Pages
EUR$197USDGBP
  • 18 Results (Page 1 of 1)
Loading Indicator

Eclampsia is a serious complication of pregnancy that can occur in the late stages of pregnancy or during labor. It is characterized by seizures, high blood pressure, and protein in the urine. It is a leading cause of maternal and infant mortality and morbidity worldwide. It is estimated that eclampsia affects up to 10% of pregnant women in some countries. Eclampsia is a major public health concern, and there is a need for improved diagnosis, treatment, and prevention. Treatment options include magnesium sulfate, antihypertensive medications, and delivery of the baby. Prevention strategies include early detection and management of high blood pressure during pregnancy, as well as improved nutrition and access to healthcare. There are a number of companies in the eclampsia market, including Bayer, Pfizer, Merck, and Novartis. These companies are focused on developing new treatments and prevention strategies for eclampsia, as well as providing education and support to healthcare providers and patients. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more